Aptevo Therapeutics (APVO) EBIT Margin (2015 - 2022)
Aptevo Therapeutics (APVO) reported EBIT Margin of -919.75% for FY2022, down 745.65 percentage points from -174.10% in FY2021.
Powered by 
Analysis
Aptevo Therapeutics (APVO) EBIT Margin (2015 - 2022) Analysis & Trends
Dating back to FY2015, Aptevo Therapeutics' EBIT Margin record includes 8 years.
- EBIT Margin has a five-year change of -551.70 percentage points (FY2017 to FY2022).
- The FY2022 figure ranks as the lowest annual EBIT Margin since FY2016.
- According to Business Quant data, EBIT Margin came in at -174.10% in FY2021 (+463.96 pp), -638.06% in FY2020 (-511.73 pp), -126.33% in FY2019 (+97.65 pp) and -223.98% in FY2018 (+144.07 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.87 Bn | 1,099.45 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 614.49 Bn | 533.02 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 502.45 Bn | 475.56 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 368.35 Bn | 322.73 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.42 Bn | 262.41 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.95 Bn | 235.64 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 235.96 Bn | 191.36 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 191.17 Bn | 165.37 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 169.80 Bn | 116.45 Bn | 10.94 Bn | 28.37% |
| 10 | Aptevo Therapeutics | 1.94 Mn | -65.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | -180.19% |
| Dec 31, 2021 | -110.23% |
| Sep 30, 2021 | -153.42% |
| Jun 30, 2021 | -183.99% |
| Mar 31, 2021 | -284.51% |
| Dec 31, 2020 | -287.36% |
| Sep 30, 2020 | -426.93% |
| Jun 30, 2020 | -1,439.11% |
| Dec 31, 2019 | -87.88% |
| Sep 30, 2019 | -127.17% |
| Jun 30, 2019 | -175.22% |
| Mar 31, 2019 | -162.92% |
| Dec 31, 2018 | -214.18% |
| Sep 30, 2018 | -208.22% |
| Jun 30, 2018 | -182.30% |
| Mar 31, 2018 | -331.64% |
| Dec 31, 2017 | -596.91% |
| Sep 30, 2017 | -167.66% |
| Jun 30, 2017 | -415.46% |
| Mar 31, 2017 | -566.34% |
API Access
Aptevo Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();